Neonatal considerations in the management of premature rupture of the fetal membranes.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002821:Chorioamnionitis / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology
D000900:Anti-Bacterial Agents